Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers

This phase I trial studies how well dolcanatide works in preventing colorectal cancer in healthy participants. Dolcanatide is similar to a natural hormone released into the intestine. It is thought that people who have low levels of the hormone are more likely to get colon cancer. It may be possible to prevent colon cancer by giving a drug that is similar to the hormone, such as dolcanatide.


Laboratory Biomarker Analysis, Placebo, Questionnaire Administration, Dolcanatide


Healthy Subject


See list of participating sites